Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) at Forefront to Advance Innovative Developments in Fight Against Lung Cancers

Clinical-stage gene-therapy company Genprex (NASDAQ: GNPX) is at the forefront to advance innovative developments in the war against lung cancers, testing its trademarked Oncoprex immunogene therapy. A recent article discussing this reads, “Oncoprex’s phase I and II clinical-stage trial therapies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities (http://ibn.fm/w3bUK). The company has a portfolio of 30 issued patents and two more pending, and it is also conducting preclinical research to help identify which patients will be most likely to benefit from its gene therapies and which additional cancer drugs will be the most synergistic with Oncoprex.”

To view the full article, visit http://ibn.fm/hDkFT

About Genprex Inc.

Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at   http://ibn.fm/GNPX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Genprex, MissionIRNewsBreaks | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing DehydraTECH Drug Delivery Platform, Innovative Products

  • Lexaria Bioscience is focusing on its pioneering DehydraTECH drug delivery technology
  • The company boasts a portfolio of unique products
  • Lexaria continues to conduct research regarding DehydraTECH technology for oral nicotine

Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Lexaria is the only global company with patents issued for the oral delivery of all cannabinoids. The company has developed and out-licenses its innovative and cost-effective DehydraTECH drug delivery platform. This technology changes the way that edible cannabinoids enter the body. DehydraTECH delivery technology offers a viable and often healthier substitute to other delivery processes for bioactive substances (http://ibn.fm/yih3f).

Lexaria Biosciences’ proprietary technology improves the taste, speed and delivery of bioactive compounds, including nicotine and cannabinoids. DehydraTECH is proven effective in multiple worldwide studies in significantly assisting the quantity of absorption of a range of lipophilic (fat-soluble) bioactive molecules. DehydraTECH also eliminates the strong tastes and odors of lipophilic compounds. Notably, this technology does so without the need for added sugar or sweeteners (http://ibn.fm/BPOdn).

Furthermore, the DehydraTECH drug delivery platform increases bio-absorption by up to 10 times and lessens the time of onset, with effects being felt within 15 to 20 minutes, as compared to 60 to 120 minutes without the platform. In addition, the technology is patent protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids. Patents are also granted for THC (tetrahydrocannabinol), other psychoactive compounds and NSAIDs (nonsteroidal, anti-inflammatory drugs), as well as nicotine and other molecules.

Lexaria Bioscience has partnered with one of the world’s largest tobacco companies to fund the research and development of the DehydraTECH technology for oral nicotine. Through wholly owned subsidiary Lexaria Nicotine LLC, Lexaria is working to propel innovation in oral, reduced-risk nicotine consumer products utilizing DehydraTECH (http://ibn.fm/1JjdR).

Lexaria’s goal is to perform an extensive series of clinical investigations of oral types of nicotine delivery, funded by its partner, using DehydraTECH technology. The DehydraTECH platform has been shown to deliver nicotine to the brain quicker than traditional delivery systems. The technology could potentially apply to the treatment of nervous system diseases, including Alzheimer’s disease. Moreover, DehydraTECH avoids the dangers associated with smoking.

Lexaria also offers a suite of diverse products (http://ibn.fm/Mnu7n). These products include protein energy bars featuring fiber and protein; ViPova exotic teas, delivering cannabidiol in numerous flavors; and coffee. The company also sells TurboCBD capsules. These are high-absorption, full-spectrum hemp oil capsules. The capsules are designed to boost focus and memory while at the same time lessening fatigue and stress. TurboCBD capsules also contain ginseng and gingko.

Lexaria Bioscience is developing a patent family with supporting intellectual property (IP) in the pharmaceutical sector. Lexaria Pharmaceutical Corp. is the company’s wholly owned subsidiary. Lexaria Pharmaceutical has acquired exclusive international rights to Lexaria’s patent portfolio regarding pharmaceutical applications (http://ibn.fm/QNwSp).

Additionally, Lexaria Hemp Co. holds exclusive international rights to the Lexaria Bioscience patent portfolio regarding hemp-based applications. The Lexaria group also includes Lexaria CanPharm Corp., a Canadian entity. Lexaria CanPharm owns exclusive international rights to Lexaria’s IP applicable to psychotropic bioactive molecules, which act upon human CB1 and CB2 receptors in permitted areas.

Lexaria Bioscience is innovating on multiple fronts. The company’s business model offers the potential for considerable ROI, as it involves developing and out-licensing its DehydraTECH platform to third-party partners and distributors for enhanced revenue. Lexaria continues to move forward with its DehydraTECH drug delivery platform and the sale of company-developed and joint venture products.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) to Host Conference Call Reviewing 2018 Financial Results

Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) this morning announced that it will host a conference call on Tuesday, April 16, 2019, at 1:00 p.m. ET to discuss its financial results for the quarter and year ended December 31, 2018. Per the update, the call will be hosted by Youngevity’s senior management, including Chairman and CEO Steve Wallach and President and CFO Dave Briskie. Interested parties can attend the call by clicking this link at least 15 minutes prior to the start time, or by dialing 206-402-0100 and entering access code 634174# at least five minutes prior to the start of the call. Additionally, an audio recording will be available for replay shortly after the conclusion of the call on the company’s corporate website.

To view the full press release, visit http://ibn.fm/yTfH9

About Youngevity International Inc.

Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business segments – a commercial coffee enterprise, a commercial hemp enterprise and an omni direct selling platform. The company features an international selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Modifies Aphria Acquisition Offer, Enters Share Repurchase Agreement

Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) this morning announced that it has reached an agreement with Aphria Inc. (TSX: APHA) (NYSE: APHA) to shorten the expiry time for acceptance of its formal offer to acquire all of the issued and outstanding common shares of Aphria from 5:00 p.m. ET on May 9, 2019, to 5:00 p.m. ET on April 25, 2019. Green Growth Brands also announced its entry into an agreement to repurchase 27,300,000 of its common shares, held by GA Opportunities Corp., for aggregate consideration of C$89 million. “We are pleased to be buying back 27,300,000 shares owned by GA Opportunities significantly below the market price and the expected sale of our toehold position of 3 million shares of Aphria, all of which will benefit our shareholders,” Peter Horvath, CEO of GGB, stated in the news release. “We are bringing our offer to an end on good terms with Aphria and are excited to turn our focus to our CBD personal care and retail cannabis businesses.”

To view the full press release, visit http://ibn.fm/6NgEi

About Green Growth Brands

Green Growth Brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by Peter Horvath, the GGB team is full of retail and consumer packaged goods experts with decades of experience building successful brands. For more information, visit the company’s website at www.GreenGrowthBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Green Growth Brands Inc. GGBXF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Retains Oak Hill Financial Inc. for IR Services

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) this morning announced that it has retained Oak Hill Financial Inc. to provide investor relations services to the company in compliance with regulatory guidelines. Per the update, Oak Hill is a Toronto-based firm that develops strategic platforms for its clients that are utilized to gain exposure and recognition in the capital markets. Oak Hill is expected to work closely with Lexaria to “develop and deploy a comprehensive capital markets strategy and campaign. Activities will include providing an investor relations program catering to retail investors, marketing services and an ongoing client services program.”

To view the full press release, visit http://ibn.fm/MeuNx

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Subsidiary Expands through Acquisition of Land

Khrysos Industries, a subsidiary of leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI), recently acquired 45 acres of land for research and development. A recent article discussing the company reads, “The company, which has been named among the ‘Top 100 Global Direct Selling Companies,’ holds a diversified portfolio of goods and services in a variety of markets. Specifically, Youngevity offers products in the top eight most profitable retail categories of health and nutrition, home and family, food and beverage (including coffee), spa and beauty, fashion, essential oils, photo and innovative services. Additionally, the company is seeking inroads to the newly profitable cannabis market. Through all of its endeavors, Youngevity assists individuals in embracing a healthy and empowered lifestyle. . . . One of Youngevity’s wholly owned subsidiaries, Khrysos Industries, is looking to substantially expand through its acquisition of a 45-acre tract of land. Plans for this tract include a research and development facility focused on hemp-plant genetic research, a five-acre greenhouse and 20 acres of farmable land. These investments are intended to increase specific yields of certain cannabinoids, which will foster the production of tissue culturing and quality hemp-seed production.”

To view the full article, visit http://ibn.fm/vdzLd

About Youngevity International Inc.

Youngevity International is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual main street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

MissionIRNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Subsidiary Capitalizing on Mounting Cannabis Business Demand for Outsourced Employment Services

Los Angeles, California-based cannabis firm Cannabis Strategic Ventures’ (OTC: NUGS) subsidiary BudHire is ideally positioned to take advantage of the rising demand for outsourced personnel solutions. A recent article discussing NUGS reads, “Supporting this rapidly growing industry is the prime strategy of Cannabis Strategic Ventures. Among the company’s subsidiaries is the aptly named BudHire, an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations. Research conducted by Glassdoor shows that cannabis job openings are increasing rapidly, with 1,512 open in the United States during December 2018 — a 76% increase over the same period in the previous year. More than 50% of those jobs are for professional and technical workers from a variety of fields, Glassdoor found (http://ibn.fm/BsmkE). . . . Cannabis Strategic Ventures and BudHire utilize a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire brand, Cannabis Strategic Ventures offers temporary, seasonal and permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry (http://ibn.fm/3mqL3).”

To view the full article, visit http://ibn.fm/YQ6Wo

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Cannabis Strategic Ventures Inc. NUGS, MissionIRNewsBreaks | Leave a comment

Net Element Inc. (NASDAQ: NETE) Revenues Grow in 2018, Total Processing Volume Also Goes Up

  • Sustainable growth in revenue mainly stemmed from the North American transaction solutions segment
  • The total processing volume also grew to reach $3.3 billion, most of which was covered by North America
  • Net Element subsidiaries like Aptito have been contributing to the U.S. market growth with the provision of cost-efficient, tailored and innovative niche services

Net Element Inc. (NASDAQ: NETE) recently announced solid financial growth in 2018. The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://ibn.fm/ZfEls).

The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed 10 percent.

In 2018, the company’s total processing volume reached $3.3 billion – an increase of 18 percent in comparison to 2017 figures. North America accounted for $2.9 billion, marking an increase of 27 percent as compared to the previous year.

According to Net Element’s management team, the North American transaction solutions segment also showed positive trends in terms of development and acquisitions. During 2018, the company acquired recurring cash flow portfolios from sales partners that are anticipated to contribute to over $9 million in gross profit over the coming four years.

The payment industry is evolving rapidly due to new technologies and changing customer needs. These market dynamics create opportunities for companies like Net Element and its subsidiaries.

Under wholly owned subsidiary Aptito, for example, Net Element provides complete business management solutions and cloud-based POS for the restaurant industry (http://ibn.fm/EYbbH). Such innovative solutions are a good choice for both large businesses and small restaurants or startups in the industry attempting to establish market position on limited budgets.

Aptito has developed a range of payment solutions tailored to the needs of various clients in the restaurant industry. These include Aptito POS, mPOS (http://ibn.fm/hib83), kiosks and digital menus. This integrated product range is favored over competitive solutions due to cost-efficiency, ease of use, simplified inventory management, improved scheduling and payroll management and cloud-enabled functionality.

The restaurant niche is characterized by rapid growth and ever-changing trends. Currently, it generates four percent of the U.S. GDP and employs more than 15 million people (http://ibn.fm/Qu20w). Due to this rapid industry growth, restaurants have to work hard to maintain competitive advantage through cost-efficient solutions and services that enable the enhancement of client satisfaction levels.

Net Element is a global financial technology and value-added solutions group that supports electronic payment acceptance in an omni-channel environment. It operates a payment-as-a-service transactional model and value-added services platform for small and medium enterprises.

In 2018, Net Element was named one of the top 10 retail payment service companies by Retail CEO Outlook. The selection of the best service providers is made on the basis of the delivery of time-focused, effective and economic payment solutions and services.

For more information, visit the company’s website at www.NetElement.com

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) to Post Q4, Full Year 2018 Financial and Operating Results on April 30

Ontario-based VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of first-class cannabis products and services to the medical and adult-use markets, announced on Wednesday that it intends to post the company’s financial and operating results for the fiscal fourth quarter and full year 2018 before the markets open on April 30, 2019.

To view the full press release, visit http://ibn.fm/P2hGh

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, VIVO Cannabis Inc. VVCIF | Leave a comment

Earth Science Tech Inc. (ETST) Gains Competitive Edge in Hemp-Derived CBD Market by Shipping Legally to All 50 States

  • Since its offerings are derived from hemp and not marijuana, Earth Science Tech’s products are fully compliant with the 2018 Farm Bill
  • Earth Science Tech offers medical, recreational and industrial hemp through its wholly owned subsidiaries
  • Each batch of the company’s CBD oil meets the strictest quality standards, positioning its offerings among the highest-quality products on the market

Earth Science Tech Inc. (OTCQB: ETST), an innovative biotechnology company operating in the fields of hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and development, is securing a commanding position in the burgeoning cannabis sector through its innovative approach and overall compliance with the 2018 Farm Bill.

Because the company’s offerings are derived from hemp and not marijuana, the products are fully compliant with the federal Farm Bill. This compliance allows the company a significant edge over competitors, because it can legally ship its Full Spectrum CBD products to all 50 states.

Earth Science Tech pairs this availability with a laser-like focus on product quality. Each batch of CBD oil is tested to ensure pharmacy-grade quality standards. As a result, the company offers some of the highest-purity and quality full-spectrum cannabinoids on the market.

Widening its distribution and industry reach, Earth Science Tech offers medical, recreational and industrial hemp through its multiple wholly owned subsidiary companies. Canna Inno Laboratories Inc. allows Earth Science Tech access to Canadian government funding and advancements gleaned from product research and development via grants offered to pharmaceutical innovators. Cannabis Therapeutics Inc. was formed as an emerging biotechnology company and is poised to become a global leader in cannabinoid research and development.

Earth Science Tech offers several variations of its High Grade Full Spectrum Cannabinoid products, including CBD Hemp Oil, CBD Capsules and CBD Pets. These products use hemp obtained through the company’s super-critical CO2 extraction to ensure the highest quality of cannabinoids and maintain all naturally occurring therapeutic properties. In the health and wellness industry, hemp products are increasingly sought-after for their incredible health benefits.

Hemp seeds (http://ibn.fm/4l3W2) are “exceptionally nutritious and rich in healthy fats, protein, and various minerals.” They make for an excellent protein source, as well as a great source of vitamin E and minerals such as phosphorus, potassium, sodium, magnesium, sulfur, calcium, iron and zinc. Earth Science Tech’s hemp products offer consumers many health benefits, including reduced risk of heart disease, digestive aid and dry skin relief.

Because of its increased revenues and income stream opportunities, Earth Science Tech is ideally poised in multiple markets that are experiencing rapid growth. The company’s diverse portfolio and pipeline encompass a wide range of cutting-edge products and devices set to expand its leadership in various market sectors.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment